openPR Logo
Press release

Ebola Vaccine Market Report 2020: Rising Impressive Business Opportunities Analysis Forecast By 2027|Industry Crucial Players- Sarepta Therapeutics, Mapp Biopharmaceutical, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc.

03-20-2020 10:45 AM CET | Health & Medicine

Press release from: Research Nester Pvt Ltd

Research Nester

Research Nester

Research Nester released a report titled "Ebola Vaccine Market: Global Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the global Ebola vaccine market in terms of market segmentation by virus type, by end user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model.

The Ebola vaccine market is projected to grow at a substantially high CAGR during the forecast period, i.e., 2020-2028. Ebola virus disease is a fatal viral disease which causes symptoms such as high fever, body aches, diarrhea and internal or external bleeding. It is highly prevalent in the African region, mainly in the Democratic Republic of the Congo (DRC). The market is segmented by virus type, by end user and by region. On the basis of virus type, the market is further segmented into Ebola virus, Sudan virus, Ta Forest virus and Bundibugyo virus. The Ebola virus segment is anticipated to hold the largest share in the Ebola vaccine market as a result of growing cases of the disease through the spread of this virus.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa, out of which, Ebola vaccine market in North America is projected to grow at the highest rate and hold the largest share. This can be attributed to the presence of leading drug manufacturers in the region, especially in the United States which are involved in research and development for new Ebola vaccines.

Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-2350

Increasing Deaths Arising from Ebola Virus Disease to Drive the Market Growth

According to the Centers for Disease Control and Prevention, the Democratic Republic of the Congo (DRC) experienced its tenth Ebola virus disease outbreak in 2019, during which a total of 3,296 cases of Ebola were reported as on November 17, 2019. Along with this, 2,196 deaths were reported as well. The World Health Organization termed this Ebola virus disease outbreak as a public health emergency of international concern on July 17, 2019.

The high number of casualties resulting from the Ebola virus disease is a major factor which is predicted to result in the growth of Ebola vaccines market over the forecast period. However, the stringent government regulations and the lengthy drug approval procedure are some factors which are estimated to restrain the market growth in near future.

This report also provides the existing competitive scenario of some of the key players of the global Ebola vaccine market which includes company profiling of Merck & Co., Inc., Sarepta Therapeutics, Mapp Biopharmaceutical, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc., Novavax, Inc., GeoVax, Tekmira Pharmaceuticals, NewLink Genetics Corporation and Bavarian Nordic. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global Ebola vaccine market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/global-online-education-market/2350

Contact Us

AJ Daniel
Email: sales@researchnester.com
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ebola Vaccine Market Report 2020: Rising Impressive Business Opportunities Analysis Forecast By 2027|Industry Crucial Players- Sarepta Therapeutics, Mapp Biopharmaceutical, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc. here

News-ID: 1977259 • Views: 488

More Releases from Research Nester Pvt Ltd

Global Online Education Market Expected to Worth USD 438.71 billion, at a CAGR o …
Research Nester has released a report titled "Online Education Market - Global Demand Analysis & Opportunity Outlook 2027" which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market share comparisons, BPS analysis, SWOT analysis and Porter's five force model. Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-2350 Technological advancements in the recent times have observed
Plywood Market: Industry Insights By Growth, Astonishing Growth, Rising Demand,I …
The global plywood market is segmented to application type such as furniture, transport, construction, packages and others. Among these segments, construction segment is anticipated to flourish in the upcoming year. Plywood market is booming across the globe on the account of growing housing population. Growing usage and demand for various plywood furniture such as table, chair, sofa and many other essentials among urban people is anticipated to impel the growth of
Virgin Coconut Oil Market: Global Industry Analysis, Technological Innovations, …
The dominant leader of coconut production across the world is Indonesia (around 180 Million tonnes). In 2017, with a production of around 150 million tonnes and 115 million tonnes, Philippines and India has the second and the third largest production of coconuts. During 2016, the organic virgin coconut oil market around the globe was valued at USD 685 Million approximately. The virgin coconut oil market has been segmented into organic virgin coconut
Smart (Intelligent) Toilet Market: Global Demand Analysis & Opportunity Outlook …
Recent report published by Research Nester titled "Smart (Intelligent) Toilet Market: Global Demand Analysis & Opportunity Outlook 2024" delivers detailed overview of the global smart (intelligent) toilet market in terms of market segmentation by type, by usage, by distribution channel and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model. The global smart

All 5 Releases


More Releases for Ebola

Ebola Vaccine Market Opportunity Analysis, 2018-2026
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus
Ebola Treatment Market: Global Industry Analysis and Forecast 2016 - 2024
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash,
2017-2022 Global Ebola Virus Vaccine Industry Forecast Report
ReportsWeb.com has announced the addition of the “Global Ebola Virus Vaccine Market Research Report 2017-2022” The report focuses on global major leading players with information such as company profiles, product picture and specification. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Ebola Virus Vaccine in these regions, from 2012 to 2022 (forecast) , covering North America, Europe,
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) – Pipeline Review, H1 2017, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline landscape. Ebola is a rare but deadly viral infection that
Ebola Drug and Vaccine Market - Global Industry Analysis 2016 - 2024
Ebola has emerged as a major hazard to mankind in recent years. Though the Ebola virus and the disease caused by it have been familiar to science for decades, the risk of a global epidemic has increased massively due to the advances in globalization. The recent outbreak of Ebola in West Africa has brought the disease in the global spotlight. Ebola starts out as a sore throat, muscle pain, headache, and